Chembio Diagnostics Return on Investment 2006-2019 | CEMI

Current and historical return on investment (ROI) values for Chembio Diagnostics (CEMI) over the last 10 years.
Chembio Diagnostics ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2019-09-30 $-0.01B $0.05B -33.33%
2019-06-30 $-0.01B $0.04B -34.92%
2019-03-31 $-0.01B $0.04B -35.40%
2018-12-31 $-0.01B $0.03B -32.32%
2018-09-30 $-0.01B $0.02B -35.44%
2018-06-30 $-0.01B $0.02B -32.43%
2018-03-31 $-0.01B $0.02B -46.15%
2017-12-31 $-0.01B $0.01B -100.00%
2017-09-30 $-0.01B $0.02B -213.33%
2017-06-30 $-0.01B inf%
2017-03-31 $-0.01B inf%
2016-12-31 $-0.01B inf%
2016-09-30 $-0.01B inf%
2016-06-30 $-0.00B inf%
2016-03-31 $-0.00B inf%
2015-12-31 $-0.00B inf%
2015-09-30 $-0.00B inf%
2015-06-30 $-0.00B inf%
2015-03-31 $-0.00B inf%
2014-12-31 $-0.00B inf%
2014-09-30 $0.00B nan%
2014-06-30 $0.00B inf%
2014-03-31 $0.00B inf%
2013-12-31 $0.00B inf%
2013-09-30 $0.00B 57.14%
2013-06-30 $0.00B 14.81%
2013-03-31 $0.00B 19.51%
2012-12-31 $0.00B $0.01B 22.22%
2012-09-30 $0.00B $0.01B 22.64%
2012-06-30 $0.00B $0.01B 25.53%
2012-03-31 $0.00B $0.01B 20.51%
2011-12-31 $0.00B $0.01B 12.50%
2011-09-30 $0.00B $0.01B 32.00%
2011-06-30 $0.00B $0.01B 36.36%
2011-03-31 $0.00B $0.01B 60.00%
2010-12-31 $0.00B $0.01B 70.59%
2010-09-30 $0.00B $0.00B 28.57%
2010-06-30 $0.00B $0.00B 30.77%
2010-03-31 $0.00B $0.00B 0.00%
2009-12-31 $0.00B $0.00B 0.00%
2009-09-30 $-0.00B $0.00B -36.36%
2009-06-30 $-0.00B $0.00B -36.36%
2009-03-31 $-0.00B $0.00B -36.36%
2008-12-31 $-0.00B $0.00B -61.54%
2008-09-30 $-0.00B $0.00B -57.14%
2008-06-30 $-0.00B $0.00B -80.00%
2008-03-31 $-0.00B $0.00B -94.12%
2007-12-31 $-0.00B $0.00B -88.89%
2007-09-30 $-0.00B $0.00B -80.00%
2007-06-30 $-0.00B $0.01B -88.89%
2007-03-31 $-0.00B $0.01B -123.08%
2006-12-31 $-0.00B $0.01B -177.78%
2006-09-30 $-0.00B $0.00B -400.00%
2006-06-30 $-0.00B $0.00B -400.00%
2006-03-31 $-0.00B $0.00B -228.57%
2005-12-31 $-0.00B $0.00B -160.00%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.071B $0.033B
CHEMBIO DIAGNOSTICS, INC. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by a third party company. Chembio markets its HIV STAT-PAK line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio also has rapid tests for veterinary tuberculosis and chagas disease. In 2007 Chembio received a U.S. patent for its Dual Path Platform technology which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP. Chembio is licensed by the U.S. Food and Drug Administration as well as the U. S. Department of Agriculture, and is certified for the global market under the International Standards Organization directive 13.485.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $148.939B 27.17
Medtronic (MDT) Ireland $146.255B 20.53
Stryker (SYK) United States $75.468B 25.38
Boston Scientific (BSX) United States $57.732B 27.25
Baxter (BAX) United States $41.294B 25.04
EssilorLuxottica Societe Anonyme (ESLOY) France $33.192B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.695B 18.63
Terumo (TRUMY) Japan $26.449B 33.01
Lonza Group Ag (LZAGY) Switzerland $25.427B 0.00
Coloplast (CLPBY) Denmark $25.186B 40.21
ResMed (RMD) United States $20.889B 38.54
Smith & Nephew SNATS (SNN) United Kingdom $18.837B 0.00
Sunny Optical Technology (SNPTF) China $16.881B 0.00
Insulet (PODD) United States $10.980B 522.38
Bio-Rad Laboratories (BIO) United States $10.534B 50.56
Hill-Rom Holdings (HRC) United States $6.940B 20.45
William Demant Holdings (WILYY) Denmark $6.665B 0.00
Perrigo (PRGO) Ireland $6.586B 12.28
Canopy Growth (CGC) Canada $6.444B 0.00
DiaSorin S.p.A (DSRLF) Italy $6.420B 0.00
Haemonetics (HAE) United States $6.070B 41.01
Shandong Weigao Medical Polymer (SHWGF) China $5.382B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.770B 29.68
Aurora Cannabis (ACB) Canada $3.652B 0.00
ICU Medical (ICUI) United States $3.620B 23.61
GW Pharmaceuticals (GWPH) United Kingdom $3.430B 0.00
Neogen (NEOG) United States $3.372B 56.42
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.059B 0.00
Quidel (QDEL) United States $2.521B 23.92
National Vision Holdings (EYE) United States $2.108B 47.59
Agios Pharmaceuticals (AGIO) United States $2.021B 0.00
Cardiovascular Systems (CSII) United States $1.495B 0.00
InMode (INMD) Israel $1.381B 0.00
VAREX IMAGING (VREX) United States $1.130B 22.63
Aphria (APHA) $1.122B 0.00
AtriCure (ATRC) United States $1.113B 0.00
Phibro Animal Health (PAHC) United States $0.936B 17.52
NanoString Technologies (NSTG) United States $0.840B 0.00
Lantheus Holdings (LNTH) United States $0.825B 20.62
Eagle Pharmaceuticals (EGRX) United States $0.798B 30.58
TG Therapeutics (TGTX) United States $0.749B 0.00
Omeros (OMER) United States $0.698B 0.00
LeMaitre Vascular (LMAT) United States $0.679B 38.16
PetIQ (PETQ) United States $0.676B 16.53
Quanterix (QTRX) United States $0.610B 0.00
Cerus (CERS) United States $0.605B 0.00
Surmodics (SRDX) United States $0.535B 55.86
HEXO (HEXO) $0.511B 0.00
OraSure Technologies (OSUR) United States $0.502B 30.11
Owens & Minor (OMI) United States $0.414B 15.30
MacroGenics (MGNX) United States $0.401B 0.00
Organigram Holdings (OGI) Canada $0.392B 0.00
Utah Medical Products (UTMD) United States $0.364B 26.36
Meridian Bioscience (VIVO) United States $0.363B 12.51
Zynex (ZYXI) United States $0.299B 33.85
BioLife Solutions (BLFS) United States $0.297B 121.58
Neptune Wellness Solutions (NEPT) Canada $0.276B 0.00
Bovie Medical (APYX) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.244B 0.00
Vapotherm (VAPO) United States $0.201B 0.00
United Health Products (UEEC) United States $0.197B 0.00
Repro-Med Systems (KRMD) United States $0.168B 0.00
InfuSystems Holdings (INFU) United States $0.152B 766.00
Cytosorbents (CTSO) United States $0.144B 0.00
Fonar (FONR) United States $0.130B 9.18
Rockwell Medical (RMTI) United States $0.129B 0.00
Female Health (VERU) United States $0.121B 0.00
Liberty Health Sciences (LHSIF) Canada $0.120B 0.00
Chimerix (CMRX) United States $0.112B 0.00
United-Guardian (UG) United States $0.089B 22.62
Nephros (NEPH) United States $0.066B 0.00
MRI Interventions (MRIC) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.050B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.045B 0.00
MTech Acquisition (KERN) United States $0.039B 0.00
ImmuCell (ICCC) United States $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.022B 0.00
Senestech (SNES) United States $0.020B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Myomo (MYO) United States $0.009B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Akers Biosciences Inc (AKER) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00